Grant: CIHR Fellowship
University of Toronto
$135,000.00
Illuminating the structure and dynamics of the proteasomal Rpn1 protein in unfolded client recognition by methyl-TROSY NMR
FY 2017-18
Summary
Human health relies on the ability to properly degrade old proteins when they are no longer needed. The degradation of proteins is carried out by an enormous protein machine called the proteasome. When protein degradation is impaired, neurodegenerative disorders such as Alzheimer's disease and amyotrophic lateral sclerosis (ALS) can occur. The proteasome contains two major pieces denoted as the core and regulatory particles (CP and RP respectively). The CP resembles a barrel with pores at each end where proteins enter for degradation. The RP is involved in recognizing and pushing old proteins into the CP to be recycled. Specifically, the RP contains a highly dynamic and multi-functional protein called Rpn1 which is crucial to recognizing and moving proteins marked for degradation into the CP. Rpn1 has been suggested to bind unfolded proteins, acting as a bridge for protein folding and degradation at the proteasome, however the details of this possibility remain unknown. A robust understanding of Rpn1 function, and therefore protein degradation, is predicated on site-specific studies of the interactions of unfolded proteins with Rpn1. We will use solution nuclear magnetic resonance (NMR) spectroscopy to investigate how Rpn1 recognizes unfolded proteins. This information will shed new light on the proteasome mechanism and will benefit the development of drugs that prevent neurodegenerative disorders.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
375860
Name
Harkness Robert
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Illuminating the structure and dynamics of the proteasomal Rpn1 protein in unfolded client recognition by methyl-TROSY NMR
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Alzheimer'S; Amyotrophic Lateral Sclerosis; Cancer; Diabetes; Dynamics; Methyl-Trosy; Nuclear Magnetic Resonance Spectroscopy; Proteasome; Protein-Folding Diseases; Rpn1
Abstract
Human health relies on the ability to properly degrade old proteins when they are no longer needed. The degradation of proteins is carried out by an enormous protein machine called the proteasome. When protein degradation is impaired, neurodegenerative disorders such as Alzheimer's disease and amyotrophic lateral sclerosis (ALS) can occur. The proteasome contains two major pieces denoted as the core and regulatory particles (CP and RP respectively). The CP resembles a barrel with pores at each end where proteins enter for degradation. The RP is involved in recognizing and pushing old proteins into the CP to be recycled. Specifically, the RP contains a highly dynamic and multi-functional protein called Rpn1 which is crucial to recognizing and moving proteins marked for degradation into the CP. Rpn1 has been suggested to bind unfolded proteins, acting as a bridge for protein folding and degradation at the proteasome, however the details of this possibility remain unknown. A robust understanding of Rpn1 function, and therefore protein degradation, is predicated on site-specific studies of the interactions of unfolded proteins with Rpn1. We will use solution nuclear magnetic resonance (NMR) spectroscopy to investigate how Rpn1 recognizes unfolded proteins. This information will shed new light on the proteasome mechanism and will benefit the development of drugs that prevent neurodegenerative disorders.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Harkness, Robert
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~